MR Spectroscopy for Assessment of Memantine Treatment in Mild to Moderate Alzheimer Dementia

Journal of Alzheimer's Disease - Netherlands
doi 10.3233/jad-2011-0021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

Cognitive Performance Predicts Treatment Decisional Abilities in Mild to Moderate Dementia

Neurology
Neurology
2006English

P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia

Frontiers in Neurology
Neurology
2012English

Nonpharmacological Treatment Options for Mild to Moderate Depression

Advances in Pulmonary Hypertension
2011English

A Phase II Trial of Huperzine a in Mild to Moderate Alzheimer Disease

Neurology
Neurology
2011English

Memantine Treatment in Patients With Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2008English

A Phase 2 Randomized Trial of ELND005, Scyllo-Inositol, in Mild to Moderate Alzheimer Disease

Neurology
Neurology
2011English

Ginkgo Biloba Extract EGb 761® in the Symptomatic Treatment of Mild-To-Moderate Dementia: A Profile of Its Use

Drugs and Therapy Perspectives
Pharmacology
2018English

Revised Criteria for Mild Cognitive Impairment May Compromise the Diagnosis of Alzheimer Disease Dementia

Archives of Neurology
2012English

Psychotropic Medication Use and Cognition in Institutionalized Older Adults With Mild to Moderate Dementia

International Psychogeriatrics
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy